REPP Sports Creatine HCL 90 Capsules | Creatine Hydrochloride
Creatine HCL is a highly concentrated form of creatine hydrochloride and is scientifically proven to help increase size, increase power, and increase strength of muscles by increasing their cell volumization. REPP Sports Creatine HCL comes in a convenient and easy to take capsule which requires no loading phase.
REPP Sports Creatine HCL Product Highlights
- Supports Strength, Endurance, and Recovery
- Boost Athletic Performance
- Faster Absorbing Form of Creatine
- No Loading Necessary
- Highly Bioavailable
Creatine HCL vs. Creatine Monohydrate
Creatine HCL is a high quality form of creatine and has many benefits such as quicker absorption rates, reduced side effects, and smaller doses. Creatine Monohydrate on the other hand has been around longer, is the most researched form of creatine, and it's incredibly affordable.
What is Creatine HCL Used For?
Creatine HCL is used for improving athletic performance and increasing muscle mass.
Take one capsule per 100 pounds of body weight, ie if you're 200 pounds take 2 capsules. Take one hour prior to training with water or beverage of your choice. On days off of training take one serving in the morning on an empty stomach.
REPP Sports Creatine HCL 90 Capsules Supplement Facts
Serving Size: 1 Capsule
Servings Per Container: 90
Creatine HCL 750mg
*Percent Daily Values are based on a 2,000 calorie diet.
Other Ingredients: Gelatin (Capsule), Silicon Dioxide, Magnesium Stearate
This product was manufactured in a plant that also processes milk, egg, soy, peanut, fish, crustaceans, tree nuts, and wheat products.
Cooper R, Naclerio F, Allgrove J, Jimenez A. Creatine supplementation with specific view to exercise/sports performance: an update. J Int Soc Sports Nutr. 2012;9(1):33. Published 2012 Jul 20. doi:10.1186/1550-2783-9-33
Wang CC, Fang CC, Lee YH, Yang MT, Chan KH. Effects of 4-Week Creatine Supplementation Combined with Complex Training on Muscle Damage and Sport Performance. Nutrients. 2018;10(11):1640. Published 2018 Nov 2. doi:10.3390/nu10111640